Krämer, I; Kaiser, J
Physicochemical Stability of Diluted Trastuzumab Infusion Solutions in Polypropylene Infusion BagsInternational Journal of Pharmaceutical Compounding. Bd. 15. H. 6. 2011 S. 515-520
Krämer, I
Qualität und NäheKrankenhauspharmazie. Bd. 32. 2011 S. 189-190
Krämer, I
Recombinant G-CSF products and what pharmacists need to knowEuropean Journal of Hospital Pharmacy Practice. Bd. 17. H. 5. 2011 S. 36-45
Krämer, I
Recombinant human insulin biosimilarsHospital Pharmacy Europe. Bd. 59. 2011 S. 46-48
Weiler, N; Thrun, I; Eberlin, M et al.
TACROLIMUS SIDE EFFECTS AFTER LIVER TRANSPLANTATION: IS THERE A DIFFERENCE BETWEEN ONCE DAILY AND TWICE DAILY FORMULATION?TRANSPLANT INTERNATIONAL. Bd. 24. 2011 S. 255-255
Kunkel, M
"Die Klinische Pharmazie in Belgien"Krankenhauspharmazie. Bd. 31. 2010 S. 147-154
Krämer, I; Kaiser, J; Walz-Jung, H
Bedeutung des Verordnungsmonitorings in der zentralen ZytostatikaherstellungKrankenhauspharmazie. Bd. 31. 2010 S. 349-357
Jekle, C; Kraemer, I
Blister Packages for Objective Therapy Compliance Measurement Validity of an innovative system for compliance measurementPHARMAZEUTISCHE INDUSTRIE. Bd. 72. H. 6. 2010 S. 1070-+
Krämer, I
Comparing echinocandins: a reviewEuropean Journal of Hospital Pharmacy Practice. Bd. 16. 2010 S. 63-67
Weiler, N; Thrun, I; Hoppe-Lotichius, M et al.
Early Steroid-Free Immunosuppression With FK506 After Liver Transplantation: Long-Term Results of a Prospectively Randomized Double-Blinded TrialTRANSPLANTATION. Bd. 90. H. 12. 2010 S. 1562-1566